David Tyronne Howton, Jr

2019

In 2019, David Tyronne Howton, Jr earned a total compensation of $4.2M as Executive Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 34% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$259,636
Option Awards$3,464,825
Salary$458,844
Other$13,318
Total$4,196,622

Howton received $3.5M in option awards, accounting for 83% of the total pay in 2019.

Howton also received $259.6K in non-equity incentive plan, $458.8K in salary and $13.3K in other compensation.

Rankings

In 2019, David Tyronne Howton, Jr's compensation ranked 2,808th out of 13,971 executives tracked by ExecPay. In other words, Howton earned more than 79.9% of executives.

ClassificationRankingPercentile
All
2,808
out of 13,971
80th
Division
Manufacturing
1,015
out of 5,698
82nd
Major group
Chemicals And Allied Products
335
out of 2,197
85th
Industry group
Drugs
272
out of 1,883
86th
Industry
Pharmaceutical Preparations
201
out of 1,395
86th

Pay ratio

David Tyronne Howton, Jr's Pay$4,196,622
Median Employee's Pay$290,714
Pay Ratio

14

to 1

In 2019, the annual total compensation of David Tyronne Howton, Jr was $4,196,622.

The annual total compensation of the median employee at Sarepta Therapeutics was $290,714.

The ratio of David Tyronne Howton, Jr's pay to the pay of median employee was therefore 14 to one.

Source: SEC filing on April 21, 2020.

Howton's colleagues

We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2019.

2019

Gilmore MMSc

Sarepta Therapeutics

Chief Scientific Officer

2019

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2019

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

2019

Douglas Ingram

Sarepta Therapeutics

Chief Executive Officer

News

In-depth

You may also like